These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20835624)

  • 1. HIV-1 RNA detection in the amniotic fluid of HIV-infected pregnant women.
    Lobato AC; Aguiar RA; Aleixo AW; Andrade BA; Cavallo IK; Kakehasi FM; Pinto JA; Melo VH
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):720-1. PubMed ID: 20835624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of HIV in amniotic fluid from HIV-infected pregnant women at full term.
    Mohlala BK; Tucker TJ; Besser MJ; Williamson C; Yeats J; Smit L; Anthony J; Puren A
    J Infect Dis; 2005 Aug; 192(3):488-91. PubMed ID: 15995963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women?
    Maiques V; García-Tejedor A; Perales A; Córdoba J; Esteban RJ
    Eur J Obstet Gynecol Reprod Biol; 2003 Jun; 108(2):137-41. PubMed ID: 12781400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
    Avram CM; Greiner KS; Tilden E; Caughey AB
    Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
    Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Dec; 61(11):1715-25. PubMed ID: 26197844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
    Garcia PM; Kalish LA; Pitt J; Minkoff H; Quinn TC; Burchett SK; Kornegay J; Jackson B; Moye J; Hanson C; Zorrilla C; Lew JF
    N Engl J Med; 1999 Aug; 341(6):394-402. PubMed ID: 10432324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
    HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group.
    Thea DM; Steketee RW; Pliner V; Bornschlegel K; Brown T; Orloff S; Matheson PB; Abrams EJ; Bamji M; Lambert G; Schoenbaum EA; Thomas PA; Heagarty M; Kalish ML
    AIDS; 1997 Mar; 11(4):437-44. PubMed ID: 9084790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013.
    Thompson DR; Momplaisir FM; Adams JW; Yehia BR; Anderson EA; Alleyne G; Brady KA
    PLoS One; 2015; 10(12):e0144592. PubMed ID: 26657902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
    Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
    Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.
    Katz IT; Leister E; Kacanek D; Hughes MD; Bardeguez A; Livingston E; Stek A; Shapiro DE; Tuomala R
    Ann Intern Med; 2015 Jan; 162(2):90-9. PubMed ID: 25599347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk of maternal-infant transmission of HIV by attacking the virus.
    Rogers MF; Shaffer N
    N Engl J Med; 1999 Aug; 341(6):441-3. PubMed ID: 10432330
    [No Abstract]   [Full Text] [Related]  

  • 15. The Brief Case: Confirmed Positive HIV-1 Serologic Screening but Undetectable RNA Virus Load in a Pregnant Woman.
    Joshi RP; Gomez CA; Steiner D; Aziz N; Pinsky BA
    J Clin Microbiol; 2017 Dec; 55(12):3316-3320. PubMed ID: 29180504
    [No Abstract]   [Full Text] [Related]  

  • 16. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
    Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
    AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
    N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women.
    Nóbrega I; Travassos AG; Haguihara T; Amorim F; Brites C
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1451-4. PubMed ID: 23731224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.